Q4 2023 Recordati Industria Chimica e Farmaceutica SpA Earnings Call Transcript
Good afternoon. Welcome and thank you for joining the Recordati Full Year 2023 Preliminary Results (Operator Instruction]. At this time, I would like to turn the conference over to Ms. Eugenia Litz, Head of Investor Relations of Recordati. Please go ahead, madam.
Thank you, Sabrina, and good afternoon, everyone. I'm pleased to be here today with Rob Koremans, our CEO; and Luigi La Corte, our CFO, who together will present the full year 2023 results. Also joining for the Q&A session will be Alberto Martinez, Executive Vice President of Specialty & Primary Care; and Scott Pescatore, Executive Vice President of Rare Diseases. As always, the presentation is available in the Investors section of our website.
It is now my pleasure to pass the call over to Rob. Please go ahead.
Good afternoon, and thank you for joining us today. Before moving on, please let me give a warm welcome to Eugenia Litz, our new Head of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
